Mydecine Speaker Series: Part III-Drug Development

Start Date : February 18, 2021
End Date : February 18, 2021
Time : 1:30 pm to3:00 pm

Email :

Get Direction View Large Map


Mydecine Speaker Series III - Drug Development

Can Psychedelic Drug Design Improve Safety and Efficacy for Medicine?

Microdose invites you to join the Mydecine Speaker Series, dedicated to the exploration of the incredible findings around the current psychedelic research and what the path to mainstream acceptance looks like.

Featuring Dr. Denton Hoyer, Drug Discovery Consultant, Mydecine Innovations Group Inc.

Robert Roscow Chief Scientific Officer and Co-Founder Mydecine Innovations Group Inc.

Debra Borchardt Co-founder and CEO of the financial news website Green Market Report

Paul A. Frewen, Ph.D., C.Psych., Associate Professor

Registration Info

Register Now

Free: CAD 0.0

Contact the Organizer

Organized by

Organized by LoveEvvnt1

Microdose Psychedelic Insights


Event Categories: Health & Nutrition.

Your Review

You must be logged in to post a comment.